Academic Bibliography

Search 200 years of publications by Ghent University researchers.

dr. Jonas Steenbrugge

Faculty of Veterinary Medicine > Department of Veterinary and Biosciences

Work address: Salisburylaan 133, D1 ingang 24
9820 Merelbeke
Email: Jonas.Steenbrugge@UGent.be
ORCID iD: 0000-0002-7763-2888

Show Sort by

Add to list
- Conference Paper
- C3
Splenic immunomodulatory effects of cisplatin in an immunocompetent intraductal model for triple-negative breast cancer

Jonas Steenbrugge (UGent) , Niels Vander Elst (UGent) , Kristel Demeyere (UGent) , Josephine De Vliegher, Annegret Van der Aa, Eric Ciamporcero, Timothy Perera and Evelyne Meyer (UGent)

(2021) OncoDot.3 symposium, Abstracts.
Add to list
- Conference Paper
- C3
Unexpected effects of a selective and potent c-MET inhibitor in an immunocompetent intraductal model for triple-negative breast cancer

Jonas Steenbrugge (UGent) , Niels Vander Elst (UGent) , Kristel Demeyere (UGent) , Olivier De Wever (UGent) , Niek Sanders (UGent) , Wim Van Den Broeck (UGent) , Annegret Van der Aa, Eric Ciamporcero, Timothy Perera and Evelyne Meyer (UGent)

(2021) OncoDot.3 symposium, Abstracts.
Add to list
- Conference Paper
- C3
Immunomodulation by cisplatin chemotherapy in an immunocompetent intraductal model for triple-negative breast cancer

Jonas Steenbrugge (UGent) , Niels Vander Elst (UGent) , Kristel Demeyere (UGent) , Josephine De Vliegher, Annegret Van der Aa, Eric Ciamporcero, Timothy Perera and Evelyne Meyer (UGent)

(2021) 18th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Abstracts.
Add to list
- Journal Article
- A1
- open access
OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer

Jonas Steenbrugge (UGent) , Niels Vander Elst (UGent) , Kristel Demeyere (UGent) , Olivier De Wever (UGent) , Niek Sanders (UGent) , Wim Van Den Broeck (UGent) , Eric Ciamporcero, Timothy Perera and Evelyne Meyer (UGent)

(2021) NPJ BREAST CANCER. 7(1).
Add to list
- Journal Article
- A1
- open access
Enterobactin deficiency in a coliform mastitis isolate decreases its fitness in a murine model : a preliminary host-pathogen interaction study

Niels Vander Elst (UGent) , Koen Breyne (UGent) , Jonas Steenbrugge (UGent) , Amanda Jane Gibson, David George Emslie Smith, Pierre Germon, Dirk Werling and Evelyne Meyer (UGent)

(2020) FRONTIERS IN VETERINARY SCIENCE. 7.
Add to list
Splenic hematopoietic and stromal cells in cancer progression

Jonas Steenbrugge (UGent) , Emiel De Jaeghere (UGent) , Evelyne Meyer (UGent) , Hannelore Denys (UGent) and Olivier De Wever (UGent)

(2020) CANCER RESEARCH. 81(1). p.27-34
Add to list
- Journal Article
- A1
- open access
Comparative profiling of metastatic 4T1- vs. non-metastatic Py230-based mammary tumors in an intraductal model for triple-negative breast cancer

Jonas Steenbrugge (UGent) , Niels Vander Elst (UGent) , Kristel Demeyere (UGent) , Olivier De Wever (UGent) , Niek Sanders (UGent) , Wim Van Den Broeck (UGent) , Luc Dirix, Steven Van Laere and Evelyne Meyer (UGent)

(2019) FRONTIERS IN IMMUNOLOGY. 10.
Add to list
- PhD Thesis
Characterization of an immunocompetent intraductal mouse model for triple-negative breast cancer

Jonas Steenbrugge (UGent)

(2019)
Add to list
- Conference Paper
- C3
Comparative immune profiling of an aggressive 4T1-based versus a non-aggressive Py230-based intraductal model for triple-negative breast cancer

Jonas Steenbrugge (UGent) , Niels Vander Elst (UGent) , Kristel Demeyere (UGent) , Olivier De Wever (UGent) , Steven Van Laere and Evelyne Meyer (UGent)

(2019) Defence is the best attack : immuno-oncology breakthroughs, 2nd EACR conference, Abstracts.
Add to list
Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models

Yves Depetter, Silke Geurs (UGent) , Rob De Vreese (UGent) , Sophie Goethals, Elien Vandoorn (UGent) , Alien Laevens, Jonas Steenbrugge (UGent) , Evelyne Meyer (UGent) , Pascal de Tullio, Marc Bracke (UGent) , et al.

(2019) INTERNATIONAL JOURNAL OF CANCER. 145(3). p.735-747

1
2

Next →